Stephanie E Perez1, Luis Diego Luna Centeno1,2, Wesley A Cheng1, Carolyn Jennifer Marentes Ruiz1, Yesun Lee1, Zion Congrave-Wilson1, Rebecca L Powell3, Lisa Stellwagen4, Pia S Pannaraj1,5. 1. Division of Infectious Diseases, Children's Hospital Los Angeles, Los Angeles, California. 2. Keck School of Medicine, University of Southern California, Los Angeles, California. 3. Division of Infectious Diseases, Department of Medicine, Icahn School of Medicine at Mount Sinai, New York, New York. 4. Department of Pediatrics, University of California, San Diego and University of California Health Milk Bank, San Diego. 5. Departments of Pediatrics and Molecular Microbiology and Immunology, Keck School of Medicine, University of Southern California, Los Angeles, California.
Abstract
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific antibodies have been detected in human milk up to 6 weeks post-coronavirus disease 2019 (COVID-19) vaccination. We evaluated SARS-CoV-2-specific antibodies, neutralization activity, effect of pasteurization, and persistence through 6 months after vaccination. METHODS: This prospective longitudinal study enrolled 30 pregnant or lactating women. SARS-CoV-2 antibodies and neutralization capacity were analyzed using an enzyme-linked immunosorbent assay compared at prevaccination and 1, 3, and 6 months postvaccination, and through Holder pasteurization. RESULTS: Human milk SARS-CoV-2-specific IgG levels peaked at 1 month postvaccination and persisted above prevaccination levels for at least 6 months (P = .005). SARS-CoV-2-specific IgA was detected at 1 and 3 months (both P < .001) but waned by 6 months compared with baseline (P = .07). Milk SARS-CoV-2-specific IgG and IgA correlated with serum IgG at the same time point (R2 = 0.37, P < .001 and R2 = 0.19, P < .001). Neutralization activity was seen in 83.3%, 70.4%, and 25.0% of milk samples at 1, 3, and 6 months postvaccination. Neutralization most strongly correlated with SARS-CoV-2-specific IgG (R2 = 0.57, P < .001). Pre- and postpasteurization samples showed similar IgG (0.84 vs 1.07, P = .36) and neutralizing activity (57.7% vs 58.7% inhibition, P = .27), but lower IgM and IgA levels postpasteurization (0.09 vs 0.06, P = .004 and 0.21 vs 0.18, P = .043). CONCLUSIONS: The data suggest that human milk SARS-CoV-2-specific antibodies may be available to milk-fed infants for up to 6 months. In addition, donor milk from vaccinated mothers retain IgG and neutralizing activity.
BACKGROUND: Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-specific antibodies have been detected in human milk up to 6 weeks post-coronavirus disease 2019 (COVID-19) vaccination. We evaluated SARS-CoV-2-specific antibodies, neutralization activity, effect of pasteurization, and persistence through 6 months after vaccination. METHODS: This prospective longitudinal study enrolled 30 pregnant or lactating women. SARS-CoV-2 antibodies and neutralization capacity were analyzed using an enzyme-linked immunosorbent assay compared at prevaccination and 1, 3, and 6 months postvaccination, and through Holder pasteurization. RESULTS: Human milk SARS-CoV-2-specific IgG levels peaked at 1 month postvaccination and persisted above prevaccination levels for at least 6 months (P = .005). SARS-CoV-2-specific IgA was detected at 1 and 3 months (both P < .001) but waned by 6 months compared with baseline (P = .07). Milk SARS-CoV-2-specific IgG and IgA correlated with serum IgG at the same time point (R2 = 0.37, P < .001 and R2 = 0.19, P < .001). Neutralization activity was seen in 83.3%, 70.4%, and 25.0% of milk samples at 1, 3, and 6 months postvaccination. Neutralization most strongly correlated with SARS-CoV-2-specific IgG (R2 = 0.57, P < .001). Pre- and postpasteurization samples showed similar IgG (0.84 vs 1.07, P = .36) and neutralizing activity (57.7% vs 58.7% inhibition, P = .27), but lower IgM and IgA levels postpasteurization (0.09 vs 0.06, P = .004 and 0.21 vs 0.18, P = .043). CONCLUSIONS: The data suggest that human milk SARS-CoV-2-specific antibodies may be available to milk-fed infants for up to 6 months. In addition, donor milk from vaccinated mothers retain IgG and neutralizing activity.
Authors: Ranawaka A P M Perera; Ronald Ko; Owen T Y Tsang; David S C Hui; Mike Y M Kwan; Christopher J Brackman; Esther M W To; Hui-Ling Yen; Kathy Leung; Samuel M S Cheng; Kin Ho Chan; Karl C K Chan; Ka-Chi Li; Linda Saif; Vanessa R Barrs; Joseph T Wu; Thomas H C Sit; Leo L M Poon; Malik Peiris Journal: J Clin Microbiol Date: 2021-01-21 Impact factor: 5.948
Authors: Kathryn J Gray; Evan A Bordt; Caroline Atyeo; Elizabeth Deriso; Babatunde Akinwunmi; Nicola Young; Aranxta Medina Baez; Lydia L Shook; Dana Cvrk; Kaitlyn James; Rose De Guzman; Sara Brigida; Khady Diouf; Ilona Goldfarb; Lisa M Bebell; Lael M Yonker; Alessio Fasano; S Alireza Rabi; Michal A Elovitz; Galit Alter; Andrea G Edlow Journal: Am J Obstet Gynecol Date: 2021-03-26 Impact factor: 8.661
Authors: Veronique Demers-Mathieu; Mark A Underwood; Robert L Beverly; Søren D Nielsen; David C Dallas Journal: Nutrients Date: 2018-05-17 Impact factor: 5.717
Authors: Erika Esteve-Palau; Araceli Gonzalez-Cuevas; M Eugenia Guerrero; Clara Garcia-Terol; M Carmen Alvarez; Geneva Garcia; Encarna Moreno; Francisco Medina; David Casadevall; Vicens Diaz-Brito Journal: Open Forum Infect Dis Date: 2022-05-11 Impact factor: 4.423
Authors: Flaminia Olearo; Laura-Sophie Radmanesh; Nadine Felber; Ronald von Possel; Petra Emmerich; Neele Pekarek; Susanne Pfefferle; Dominik Nörz; Gudula Hansen; Anke Diemert; Martin Aepfelbacher; Kurt Hecher; Marc Lütgehetmann; Petra Clara Arck; Ann-Christin Tallarek Journal: J Reprod Immunol Date: 2022-08-04 Impact factor: 3.993
Authors: Yesica Longueira; Diego S Ojeda; Rocio B Antivero Battistelli; Lautaro Sanchez; Santiago Oviedo Rouco; Daniel Albano; Eleonora Guevara; Vanesa Valls; María A Pando; Andrea V Gamarnik Journal: Front Immunol Date: 2022-10-03 Impact factor: 8.786